Dashboard
Manage Tickers

ACONWAclarion, Inc.

Nasdaq aclarion.com


$ 0.05 $ 0.00 (9.59 %)    

Thursday, 02-May-2024 09:49:23 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 472.49 $ -2.05 (-0.43 %)
DIA $ 416.26 $ -1.07 (-0.26 %)
SPY $ 562.20 $ -1.67 (-0.3 %)
TLT $ 99.62 $ -1.25 (-1.24 %)
GLD $ 235.53 $ -1.83 (-0.77 %)
$ 0.04
-- x --
-- x --
-- - --
$ 0.01 - $ 0.15
8,648
na
1.52M
$ 0.62
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-14-2024 06-30-2024 10-Q
2 05-15-2024 03-31-2024 10-Q
3 03-28-2024 12-31-2023 10-K
4 11-14-2023 09-30-2023 10-Q
5 08-25-2023 06-30-2023 10-Q
6 07-03-2023 03-31-2023 10-Q
7 02-27-2023 12-31-2022 10-K
8 11-14-2022 09-30-2022 10-Q
9 08-15-2022 06-30-2022 10-Q
10 06-06-2022 03-31-2022 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles
Aclarion's Nociscan Gains Second Payer Cov...
07/09/2024 11:03:09

Aclarion, Inc., ("Aclarion" or the "Company") (NASDAQ:ACON, ACONW)))), a healthcare technology company that is ...

Core News & Articles
Trading Halt: Halt status updated at 9:00:...
01/04/2024 14:00:04

Core News & Articles
Trading Halt: Halted at 7:50:00 p.m. ET - ...
01/04/2024 00:50:04

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION